Cytotoxicity of adenoviral-mediated cytosine deaminase plus 5-fluorocytosine gene therapy is superior to thymidine kinase plus acyclovir in a human renal cell carcinoma model.
about
Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)Hypoxia-targeted triple suicide gene therapy radiosensitizes human colorectal cancer cellsGene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives.Safeguarding nonhuman primate iPS cells with suicide genes.Gene-directed enzyme prodrug therapy.Enzyme/Prodrug Systems for Cancer Gene Therapy.Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity.Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus.Cytosine deaminase and thymidine kinase gene therapy in a Dunning rat prostate tumour model: absence of bystander effects and characterisation of 5-fluorocytosine metabolism with 19F-NMR spectroscopy.Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy.The combination of HSV-tk and endostatin gene therapy eradicates orthotopic human renal cell carcinomas in nude mice.Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumors.
P2860
Q24792836-C3108249-479E-4C81-998E-5BD82F81A19AQ33881694-D5007EDD-4456-4145-A917-26DD7210AE69Q34176439-388B8945-5659-497F-843C-9EA57BBEC5F2Q35238279-435AACB9-851B-4E10-9284-ACE499662458Q38262019-BB37D626-DF5D-4808-8929-9446110CC51FQ39064497-1DC580B2-F497-4E77-B62B-BF480E097940Q40388169-5A264032-D883-48CF-B3C2-C1FBDCAAA31DQ40551014-B8FFB6AE-AFBC-41BC-8BCF-10724F4DC4D1Q40691164-5037DACE-2931-4F33-9EE2-C29616B9B197Q41882677-721624DB-8CA0-476C-BE18-E5998BE978A1Q44184293-63461143-7E15-4C38-923B-E85A804C204AQ45411954-40C199AE-66B1-46F2-B603-EBC4E599049B
P2860
Cytotoxicity of adenoviral-mediated cytosine deaminase plus 5-fluorocytosine gene therapy is superior to thymidine kinase plus acyclovir in a human renal cell carcinoma model.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cytotoxicity of adenoviral-med ...... an renal cell carcinoma model.
@ast
Cytotoxicity of adenoviral-med ...... an renal cell carcinoma model.
@en
type
label
Cytotoxicity of adenoviral-med ...... an renal cell carcinoma model.
@ast
Cytotoxicity of adenoviral-med ...... an renal cell carcinoma model.
@en
prefLabel
Cytotoxicity of adenoviral-med ...... an renal cell carcinoma model.
@ast
Cytotoxicity of adenoviral-med ...... an renal cell carcinoma model.
@en
P2093
P1476
Cytotoxicity of adenoviral-med ...... an renal cell carcinoma model.
@en
P2093
Gardner TA
Kamidono S
Shirakawa T
P304
P356
10.1097/00005392-199909010-00096
P407
P433
P577
1999-09-01T00:00:00Z